Keyphrases
Patient-derived Xenograft
100%
Triple-negative Breast Cancer
80%
Breast Cancer
53%
Tumor
49%
Breast Cancer Patients
44%
Estrogen Receptor 1 (ESR1)
41%
Breast Cancer Xenograft
25%
Patient-derived Tumor Xenograft
24%
Endocrine Therapy
21%
Proteomics
19%
Metastatic Breast Cancer
18%
Xenograft
18%
Proteogenomics
17%
Tumor Growth
16%
Metastasis
16%
Patient-derived
16%
Response Predictors
14%
Mass Spectrometry
14%
ESR1 mutation
12%
Basal-like
12%
Human Epidermal Growth Factor Receptor 2 (HER2)
12%
Breast Tumor
12%
Endocrine Resistance
11%
Response to Therapy
11%
Proteome
11%
Phosphorylation
11%
Targeted Therapy
11%
Targeted Treatment
11%
Endocrine-resistant Breast Cancer
11%
PI3K Inhibitor
11%
Chemotherapy Resistance
10%
Proteomic Analysis
10%
Therapy-resistant
10%
Radiomics
10%
Primary Breast Cancer
10%
Magnetic Resonance Imaging
10%
Cyclin-dependent Kinase 4 (CDK4)
10%
Estrogen Receptor
10%
Pathway Activity
10%
Mammalian Target of Rapamycin (mTOR)
10%
Poor Prognosis
9%
Eribulin
9%
Cancer Xenograft
9%
Engraftment
9%
Hormonal Stimulation
9%
Chemotherapy Response
9%
Copy number Profiling
9%
Comprehensive Characterization
9%
Radiomics Signature
9%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
9%
Biochemistry, Genetics and Molecular Biology
Proteomics
54%
Genomics
33%
Cancer Cell
32%
Estrogen Receptor
27%
Tumor Progression
21%
Proteome
21%
Kinase
21%
Phosphotransferase
21%
Proteogenomics
19%
DNA Sequence
16%
Carcinogenesis
15%
Transcriptomics
14%
Gene Expression
14%
Radiomics
14%
Ligand Binding Domain
12%
Quantitative Proteomics
12%
YAP1
11%
Mass Spectrometry
10%
RNA Sequence
10%
Drug Resistance
9%
Reprogramming
9%
Somatic Mutation
9%
Phosphoinositide 3-Kinase
9%
Gene Amplification
9%
Programmed Cell Death
9%
Cyclin-Dependent Kinase 4
9%
Cyclin-Dependent Kinase 6
9%
Growth Inhibition
9%
Clinical Trial
9%
Mesenchymal-Epithelial Transition
8%
Magnetic Resonance Imaging
8%
Epidermal Growth Factor Receptor
8%
Kinome
8%
Estrogen Receptor Alpha
8%
Phosphoprotein
8%
Gene Fusion
8%
Mouse Model
7%
C-Terminus
7%
Genetics
7%
Neratinib
7%
Preclinical Study
7%
Pan-cancer
7%
Tandem Mass Spectrometry
7%
Tumor Volume
7%
Antineoplastic Activity
6%
Protein Expression
6%
Phosphoproteomics
6%
Drug Response
6%
Copy Number Analysis
6%
Phosphoproteome
6%
Medicine and Dentistry
Breast Cancer
69%
Xenograft
65%
Triple Negative Breast Cancer
37%
Neoplasm
35%
Tumor Xenograft
29%
Hormone Therapy
27%
Metastatic Carcinoma
23%
Malignant Neoplasm
17%
Polyethylene Terephthalate
15%
Radiomics
14%
Tumor Progression
13%
Positron Emission Tomography
12%
Diseases
12%
CDK4/6 Inhibitor
12%
Therapy Resistance
10%
Neoadjuvant Chemotherapy
10%
Metastatic Breast Cancer
9%
Basal Like Breast Cancer
9%
Estrogen Receptor
9%
Primary Tumor
8%
In Vitro
8%
Zirconium 89
7%
Clinical Trial
7%
Palbociclib
7%
Biological Marker
7%
Estrogen Receptor Positive Breast Cancer
6%
Magnetic Resonance Imaging
6%
Cancer Research
6%
Phosphotransferase
6%
Epidermal Growth Factor Receptor
6%
Cancer
6%
Drug Resistance
6%
Tumor Imaging
5%
DNA Mismatch Repair
5%
Fluorodeoxyglucose F 18
5%
Cell Mutant
5%
Carcinogenesis
5%
Solid Malignant Neoplasm
5%
Cell Cycle Regulation
5%
Tyrosine-Kinase Inhibitor
5%
Organoid
5%